Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 6/20 | 0.59 |
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | BCHE | P06276 | 3/20 | 0.59 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.59 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.59 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.59 |
| ▸ | MAOB | P27338 | 2/20 | 0.59 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.59 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.59 |
| ▸ | ACHE | P22303 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.55 |
| ▸ | AKT1 | P31749 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.53 |
| ▸ | RELA | Q04206 | 4/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL314323 | 1.00 | RECQL (0.61) | RECQLMAPTLMNABCHEPLIN1 | |
| SCHEMBL3412403 | 1.00 | RECQL (0.61) | RECQLMAPTLMNABCHEPLIN1 | |
| SCHEMBL21065368 | 0.92 | ALDH1A1 (0.56) | RECQLMAPTLMNABCHEPLIN1 | |
| SCHEMBL22572689 | 0.86 | RECQL (0.52) | RECQLMAPTLMNABCHEPLIN1 | |
| SCHEMBL2954318 | 0.85 | MAPT (0.70) | RECQLMAPTLMNABCHEPLIN1 | |
| SCHEMBL11073619 | 0.85 | MAPT (0.70) | RECQLMAPTLMNABCHEPLIN1 | |
| SCHEMBL2954324 | 0.85 | MAPT (0.70) | RECQLMAPTLMNABCHEPLIN1 | |
| SCHEMBL19209055 | 0.85 | RECQL (0.55) | RECQLMAPTLMNABCHEPLIN1 | |
| SCHEMBL19209057 | 0.85 | RECQL (0.55) | RECQLMAPTLMNABCHEPLIN1 | |
| SCHEMBL28801232 | 0.84 | ALDH1A1 (0.46) | RECQLMAPTLMNABCHEPLIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 500 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250163014-A1 | PRODUCTION METHOD FOR EPISULFIDE COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-05-22 | — | — | US | claimed |
| EP-4491621-A1 | PRODUCTION METHOD FOR EPISULFIDE COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-01-15 | — | — | EP | claimed |
| CN-118829634-A | Method for producing episulfide compound | 三菱瓦斯化学株式会社 | 2024-10-22 | — | — | CN | claimed |
| WO-2023171591-A1 | PRODUCTION METHOD FOR EPISULFIDE COMPOUND | 三菱瓦斯化学株式会社 | 2023-09-14 | — | — | WO | claimed |
| CN-113292430-B | Alpha-carbonyl alkenyl ester compound and preparation method and application thereof | 江西师范大学 | 2022-11-29 | — | — | CN | claimed |
| CN-111471262-A | Preparation method of low-thermal-resistance filling material for high-voltage cable | 东阳市聚冉电子科技有限公司 | 2020-07-31 | — | — | CN | claimed |
| CN-111378287-A | Preparation method of high-temperature-resistant cable sheath material | 东阳市聚冉电子科技有限公司 | 2020-07-07 | — | — | CN | claimed |
| CN-106478454-B | A kind of cyan-acetic ester is to α, β-unsaturation ketenes Process for the cyanation | 泰莱斯（南通）医药化工有限公司 | 2019-01-01 | — | — | CN | claimed |
| CN-106478454-A | A kind of Process for the cyanation of cyan-acetic ester to α, β unsaturation ketenes | 泰莱斯（南通）医药化工有限公司 | 2017-03-08 | — | — | CN | claimed |
| CN-104086535-B | 3,3 '-dibasic 3-oxidizable pyrrole benzazolyl compounds and method of asymmetric synthesis thereof | 成都丽凯手性技术有限公司 | 2016-07-27 | — | — | CN | claimed |
| EP-0393457-B1 | Proteinase inhibitor | SUNTORY LTD (JP) | 1994-07-06 | — | — | EP | claimed |
| EP-0292808-B1 | Substituted vinyl cephalosporins, process for their preparation and their use as medicines | BAYER AG (DE) | 1994-03-02 | — | — | EP | claimed |
| US-5276024-A | 3-substituted cephalosporins, and their use as medicaments | BAYER AKTIENGESELLSCHAFT (DE) | 1994-01-04 | — | — | US | claimed |
| EP-0504938-A2 | Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient | SUNTORY LIMITED (JP) | 1992-09-23 | — | — | EP | claimed |
| EP-0393457-A1 | Proteinase inhibitor | SUNTORY LIMITED (JP) | 1990-10-24 | — | — | EP | claimed |
| CN-88103202-A | Vinyl cephalosporin compound that replaces and preparation method thereof and as the application of medicine | — | 1988-12-21 | — | — | CN | claimed |
| EP-0292808-A2 | Substituted vinyl cephalosporins, process for their preparation and their use as medicines | BAYER AG (DE) | 1988-11-30 | — | — | EP | claimed |
| EP-0292806-A2 | Substituted vinyl cephalosporins, process for their preparation and their use as medicines | BAYER AG (DE) | 1988-11-30 | — | — | EP | claimed |
| EP-0132764-A2 | Derivatives of dihydrodibenzocycloheptylidene-ethylamine | SOCIEDAD ESPANOLA DE ESPECIALIDADES FARMACO-TERAPEUTICAS, S.A. (ES) | 1985-02-13 | — | — | EP | claimed |
| US-3951884-A | STYRENE OR METHYL METHACRYLATE-DIENE-UNSATURATED KETONE | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1976-04-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250163014-A1 | PRODUCTION METHOD FOR EPISULFIDE COMPOUND | SULT1E1, ESR2, MRPL21 | RECQL 2794/4885MAPT 4728/4885LMNA 4291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.